|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.810 USD | +3.22% |
|
+16.46% | +198.76% |
Company Valuation: MacroGenics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 983.2 | 412.5 | 596.7 | 204 | 101.8 | 305.7 | - | - |
| Change | - | -58.04% | 44.66% | -65.82% | -50.07% | 200.2% | - | - |
| Enterprise Value (EV) | 983.2 | 412.5 | 366.9 | 204 | 101.8 | 305.7 | 305.7 | 305.7 |
| Change | - | -58.04% | -11.05% | -44.41% | -50.07% | 200.2% | 0% | 0% |
| P/E | -4.76x | -3.44x | -64.1x | -3.04x | -1.36x | -7.17x | -3.15x | -2.43x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.1x | 0.7x | -0x | -0.1x | 0.2x | -0x | -0.1x |
| Capitalization / Revenue | 12.7x | 2.71x | 10.2x | 1.36x | 0.68x | 1.86x | 3.24x | 2.27x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.86x | 3.24x | 2.27x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.6x | -2.16x | -2.1x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | 12.4x | -2.11x | -2.24x |
| FCF Yield | -15.3% | -22% | -13.4% | -35.3% | -81.5% | 8.09% | -47.3% | -44.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.37 | -1.95 | -0.15 | -1.07 | -1.18 | -0.6707 | -1.528 | -1.98 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 77.45 | 151.9 | 58.75 | 150 | 149.5 | 164.4 | 94.26 | 135 |
| EBITDA | -191.5 | -109.6 | -158.6 | - | - | - | - | - |
| EBIT 1 | -202.8 | -121.4 | -168.2 | -110.6 | -72.84 | -85.03 | -141.3 | -145.9 |
| Net income 1 | -202.1 | -119.8 | -9.058 | -66.97 | -74.62 | -18.31 | -127 | -167.8 |
| Net Debt | - | - | -229.8 | - | - | - | - | - |
| Reference price 2 | 16.050 | 6.710 | 9.620 | 3.250 | 1.610 | 4.810 | 4.810 | 4.810 |
| Nbr of stocks (in thousands) | 61,258 | 61,475 | 62,029 | 62,763 | 63,259 | 63,563 | - | - |
| Announcement Date | 2/24/22 | 3/15/23 | 3/7/24 | 3/20/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.17x | - | - | - | 306M | ||
| 34.2x | 8.53x | 26.72x | 0.05% | 55.63B | ||
| 19.78x | 6x | 13.04x | 1.52% | 52.25B | ||
| -18.16x | 4.33x | -7.56x | -.--% | 23.07B | ||
| -39.15x | 12.94x | -37.74x | -.--% | 22.41B | ||
| 21.62x | 4.23x | 10.97x | -.--% | 17.32B | ||
| 22.36x | 4.48x | 14.84x | -.--% | 15.94B | ||
| 44.46x | 16.86x | 51x | -.--% | 13.47B | ||
| 17.25x | 5x | 11.74x | -.--% | 13.77B | ||
| -436.4x | 29.85x | -3327.81x | -.--% | 12.43B | ||
| Average | -34.12x | 10.25x | -360.53x | 0.18% | 22.66B | |
| Weighted average by Cap. | -9.79x | 8.79x | -172.08x | 0.36% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MGNX Stock
- Valuation MacroGenics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















